Applied Genetic Technologies Corp IPO Research Information

Applied Genetic Technologies Corp IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Applied Genetic Technologies Corp, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Applied Genetic Technologies Corp	AGTC - NASDAQ	$13.00-$15.00	$12.00	$12.75	4.2 million	3/27/2014
Underwriter(s): BMO Capital Markets, Wedbush PacGrow Life Science
Co-Manager(s): Cantor Fitzgerald & Co., Roth Capital Partners
Industry: Health Care
Filing(s): Filed 2014-01-10 Terms Added 2014-03-12

Applied Genetic Technologies Corp Quote & Chart - Click for current quote - AGTC

About Applied Genetic Technologies Corp (adapted from Applied Genetic Technologies Corp prospectus):
They are a clinical-stage biotechnology company that uses our proprietary gene therapy platform to develop products designed to transform the lives of patients with severe inherited orphan diseases in ophthalmology.

This description is adapted from Applied Genetic AGTC prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Applied Genetic AGTC "AGTC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.